218 related articles for article (PubMed ID: 2988259)
1. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T
Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259
[TBL] [Abstract][Full Text] [Related]
2. ACTH and beta-endorphin secretion by three corticotrophic adenomas in culture. Effects of culture time, dexamethasone, vasopressin and synthetic corticotrophin releasing factor.
Oosterom R; Verleun T; Uitterlinden P; Hackeng WH; Burbach JP; Wiegant VM; Lamberts SW
Acta Endocrinol (Copenh); 1984 May; 106(1):21-9. PubMed ID: 6328819
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
Müller OA; Hartwimmer J; Hauer A; Kaliebe T; Schopohl J; Stalla GK; von Werder K
Psychoneuroendocrinology; 1986; 11(1):49-60. PubMed ID: 3010360
[TBL] [Abstract][Full Text] [Related]
4. [Studies for clinical application of ovine corticotropin-releasing factor].
Kubo M
Hokkaido Igaku Zasshi; 1985 Mar; 60(2):282-98. PubMed ID: 2987091
[TBL] [Abstract][Full Text] [Related]
5. Effects of bromocriptine and cyproheptadine on basal and corticotropin-releasing factor (CRF)-induced ACTH release in a patient with Nelson's syndrome.
Hirata Y; Nakashima H; Uchihashi M; Tomita M; Fujita T; Ikeda M
Endocrinol Jpn; 1984 Oct; 31(5):619-26. PubMed ID: 6097444
[TBL] [Abstract][Full Text] [Related]
6. [Lipocorticotropic peptides in Cushing's disease: in vitro studies].
Boudouresque F; Lissitzky JC; Jaquet P; Guibout M; Goldstein E; Grisoli F; Oliver C
Horm Res; 1980; 13(4-5):242-58. PubMed ID: 6268512
[TBL] [Abstract][Full Text] [Related]
7. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
[TBL] [Abstract][Full Text] [Related]
9. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
10. The effect of ovine corticotrophin releasing factor (oCRF), bromocriptine and TRH on the secretion of ACTH and alpha-MSH in Nelson's syndrome and Cushing's disease.
Abraham RR; Campbell EA; Gillham B; Thody AJ; Altaher AR; Prysor-Jones A; Wynn V; Jones MT; Jenkins J
Clin Endocrinol (Oxf); 1986 Jul; 25(1):75-85. PubMed ID: 3024873
[TBL] [Abstract][Full Text] [Related]
11. ACTH, beta-LPH and beta-endorphin in pituitary adenomas of the patients with Cushing's disease: activation of beta-LPH conversion to beta-endorphin.
Suda T; Abe Y; Demura H; Demura R; Shizume K; Tamahashi N; Sasano N
J Clin Endocrinol Metab; 1979 Sep; 49(3):475-7. PubMed ID: 224076
[TBL] [Abstract][Full Text] [Related]
12. FK 33-824, a met-enkephalin analog, blocks corticotropin-releasing hormone-induced adrenocorticotropin secretion in normal subjects but not in patients with Cushing's disease.
Allolio B; Deuss U; Kaulen D; Leonhardt U; Kallabis D; Hamel E; Winkelmann W
J Clin Endocrinol Metab; 1986 Dec; 63(6):1427-31. PubMed ID: 3023423
[TBL] [Abstract][Full Text] [Related]
13. Secretion of adrenocorticotropin, beta-endorphin and calcitonin by cultured medullary thyroid carcinoma cells. Effects of synthetic corticotropin-releasing factor and lysine vasopressin.
Oosterom R; Verleun T; Bruining HA; Hackeng WH; Lamberts SW
Acta Endocrinol (Copenh); 1986 Sep; 113(1):65-72. PubMed ID: 3020852
[TBL] [Abstract][Full Text] [Related]
14. Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness.
Pecori Giraldi F; Marini E; Torchiana E; Mortini P; Dubini A; Cavagnini F
J Endocrinol; 2003 Jun; 177(3):373-9. PubMed ID: 12773117
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro.
Shibasaki T; Nakahara M; Shizume K; Kiyosawa Y; Suda T; Demura H; Kuwayama A; Kageyama N; Benoit R; Ling N
J Clin Endocrinol Metab; 1983 Feb; 56(2):414-6. PubMed ID: 6130101
[TBL] [Abstract][Full Text] [Related]
16. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
[TBL] [Abstract][Full Text] [Related]
17. Long-term culture of human corticotropin-secreting adenomas on extracellular matrix and evaluation of serum-free conditions. Secretory aspects.
Westphal M; Jaquet P; Wilson CB
Acta Neuropathol; 1986; 71(1-2):111-8. PubMed ID: 3022531
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin releasing factor (CRF): diagnostic implications.
Müller OA; Stalla GK; Hartwimmer J; Schopohl J; von Werder K
Acta Neurochir (Wien); 1985; 75(1-4):49-59. PubMed ID: 2986422
[TBL] [Abstract][Full Text] [Related]
19. In vitro secretion of pro-opiomelanocortin (POMC) derived peptides in human ACTH-producing pituitary adenomas: evaluation of hormone ratios in different functional states.
Westphal M; Lüdecke DK
Mol Cell Endocrinol; 1984 Sep; 37(2):145-51. PubMed ID: 6092171
[TBL] [Abstract][Full Text] [Related]
20. Effects of corticotropin-releasing factor and other materials on adrenocorticotropin secretion from pituitary glands of patients with Cushing's disease in vitro.
Suda T; Tomori N; Tozawa F; Demura H; Shizume K
J Clin Endocrinol Metab; 1984 Nov; 59(5):840-5. PubMed ID: 6148354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]